Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Arterial chemoembolization for hepatocellular carcinoma.

Jian Fan, Gao-Jing Ten, Shi-Cheng He

    World Journal of Gastroenterology
    |January 31, 2002
    PubMed
    Summary

    Transcatheter arterial three-segment chemoembolization effectively treats hepatocellular carcinoma (HCC). This method demonstrated significant partial and minor response rates, improving patient survival outcomes.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Primary Liver Cancer Trends Worldwide and in China: Analysis of GLOBOCAN 2022 Data and Disease Management Implications.

    Portal hypertension & cirrhosis·2026
    Same author

    An intramolecular self-catalysis-boosted electrochemiluminescence biosensor for alpha fetoprotein detection in serum samples from liver cancer patients.

    Talanta·2026
    Same author

    Impact of modified Henry approach with preservation of Flexor Carpi Radialis Tendon Sheath on wrist function in the treatment of distal radius fractures.

    Archives of orthopaedic and trauma surgery·2026
    Same author

    Teaching NeuroImage: Bilateral Sturge-Weber Syndrome With Dyke-Davidoff-Masson Syndrome Changes.

    Neurology·2026
    Same author

    Progress of transgenic pigs in liver xenotransplantation.

    Liver research (Beijing, China)·2026
    Same author

    NQO1-Mediated Anoikis Resistance and Immune Evasion Define a High-Risk Multi-Omic Subtype for Precision Management of T1 High-Grade Bladder Cancer.

    Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

    Area of Science:

    • Interventional Radiology
    • Oncology
    • Hepatology

    Background:

    • Hepatocellular carcinoma (HCC) is a primary liver cancer with limited treatment options.
    • Transcatheter arterial chemoembolization (TACE) is a standard treatment for unresectable HCC.
    • Optimizing TACE techniques is crucial for improving therapeutic efficacy.

    Purpose of the Study:

    • To evaluate the therapeutic effects of a novel transcatheter arterial three-segment chemoembolization regimen for hepatocellular carcinoma (HCC).
    • To assess the response rates and survival outcomes in HCC patients treated with this TACE method.

    Main Methods:

    • A series of 80 hepatocellular carcinoma (HCC) patients were treated using transcatheter arterial chemoembolization.
    • The procedure involved sequential occlusion of tumor capillary networks, muscular arterioles, and feeding arteries.

    Related Experiment Videos

  • Lipiodol ultra-fluid (LUF), sinobufagin microsphere (SBMs), and particles of gelatin sponge (PGS) were used for embolization.

    • Main Results:

    • Therapeutic effects were evaluated in 76 patients.
    • Partial response was observed in 22 cases (28.9%), and minor response in 41 cases (53.9%).
    • The 6-month, 1-year, 2-year, and 3-year survival rates were 97.4%, 86.8%, 46.1%, and 27.6%, respectively.

    Conclusions:

    • The transcatheter arterial three-segment chemoembolization regimen is a rational and effective treatment strategy for HCC.
    • This approach demonstrated promising response rates and improved survival in HCC patients.
    • Further research may explore this technique for broader clinical application in liver cancer management.